CPMG Inc

Q2 2021 13F Holdings Report, Options Holdings

Signature - Title
John E. Bateman - Chief Operating Officer
Location
Dallas, TX
Options holdings as of
June 30, 2021
Notional value $
$0
Number of holdings
0
Date filed
8/16/2021, 04:11 PM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q1 2021 - May 17, 2021
Stock holdings
Showing options holdings, see here for stock holdings

CPMG Inc didn't report any options holdings as of Q2 2021. Check stock holdings.

Filing 2021 Q2 compared to 2021 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
John E. Bateman Chief Operating Officer Dallas, Texas 7/28/2021

This Form 13F includes only the reportable 2,896,901 Class A shares of Reata Pharmaceuticals, Inc. ("Reata") over which CPMG, Inc. ("CPMG") had investment discretion as of June 30, 2021. This Form 13F does not include the 1,692,857 Class B shares of Reata over which CPMG had investment discretion as of June 30, 2021 because such Class B shares were not included in the relevant quarter's Official List of Section 13(f) Securities, and thus should be excluded.